BTV Examines the Rapidly Expanding Psychedelics Market

BTV-Business Television explores the burgeoning sector that has captured the attention of investors – psychedelics.

Discover Companies to Invest In – Click company name to watch their TV feature:

Entheon Biomedical Corp. (CSE: ENBI, OTCQB: ENTBF)

Researching and developing DMT, one of the most powerful psychedelics in existence, to address substance use disorders related to nicotine, alcohol, and opioids.

Psyched Wellness Ltd. (CSE: PSYC, OTCQB: PSYCF)

BTV reports on their pre-clinical studies underway with a proprietary extract from the Amanita Muscaria mushroom. Psyched Wellness was created with the purpose of benefitting the health of people, plants and the planet.

Small Pharma Inc. (TSX.V: DMT)

BTV learns about DMT, a psychedelic that is the subject of a Small Pharma clinical trial dealing with depression – the world’s first. Small Pharma initiated a clinical program into DMT-assisted therapy in February 2021. Elemer Piros, Analyst at Roth Capital Partners, weighs in.

Numinus Wellness Inc. (TSX.V: NUMI)

BTV checks in with a company at the forefront of a new and innovative mental health treatment focused on psychedelic-assisted psychotherapy. The company is looking to transform the mental health landscape.

Mydecine Innovations Group (NEO: MYCO, OTC: MYCOF)

BTV discovers how this company is developing psilocybin-based psychedelic treatments to better address the effects of addiction and post-traumatic stress disorder.

On air for over 20 years, BTV – Business Television, a half-hour investment TV show, features analysts and emerging publicly traded companies at their location. With Hosts, Taylor Thoen and Jessica Katrichak, BTV provides viewers with investment opportunities.


US National TV:
Biz Television Network – Sun Aug 1 @ 8:30am EST

Suggest a Company to Feature!
Contact: (604) 664-7401 x3
To receive news, click here to subscribe.